Evidence map›Paper›PMID 40083943›Full record

ReviewTheranostics2025

Unveiling the potential of biomechanics in pioneering innovative strategies for cancer therapy.

Xiaodong Wu, Weidong Fei, Tao Shen, Lei Ye, Chaoqun Li, Siran Chu, Mingqi Liu, Xiaodong Cheng, Jiale Qin

Abstract readReview
In one paragraph

Review in Theranostics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. PIEZO2 in tumors: from mechanobiological switches to activity-targeted therapies.Journal of experimental & clinical cancer research : CR · 2025
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiaodong WuWomen's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
Weidong FeiWomen's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
Tao ShenWomen's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
Lei YeWomen's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
Chaoqun LiWomen's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
Siran ChuZhejiang University School of Medicine, Hangzhou, 310000, China.
Mingqi LiuWomen's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
Xiaodong ChengWomen's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
Jiale QinWomen's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mechanical force transmission is pivotal in tumor biology, profoundly affecting cancer cell behaviors such as proliferation, metastasis, and resistance to therapy. To explore novel biomechanical-based therapeutic strategies for cancer treatment, this paper deciphers the advances in biomechanical measurement approaches and the impact of biomechanical signals on fundamental oncological processes such as tumor microenvironment remodeling, angiogenesis, metastasis, and drug resistance. Then, the mechanisms of biomechanical signal transduction of tumor cells are demonstrated to identify novel targets for tumor therapy. Additionally, this study proposes a novel tumor treatment strategy, the biomechanical regulation tumor nanotherapeutics, including smart biomaterials designed to disturb mechanical signaling pathways and innovative nanodrugs that interfere transduction of biomechanical signals to improve tumor therapeutic outcomes. These methods mark a departure from conventional pharmacological therapies to novel strategies that utilize mechanical forces to impede tumor progression and enhance tumor responsiveness to treatment. In general, this review highlights the critical role of biomechanical signals in cancer biology from a holistic perspective and underscores the potential of biomechanical interventions as a transformative class of therapeutics. By integrating mechanobiology into the development of cancer treatments, this paper paves the way for more precise and effective strategies that leverage the inherent physical properties of the tumor microenvironment.

Indexed as

NeoplasmsAnimalsAntineoplastic AgentsBiomechanical PhenomenaHumansSignal TransductionTumor MicroenvironmentAntineoplastic Agentsbiomechanicscancermechanosensorsmechanosignaling proteinsnanotherapeutics

Identifiers

PMID40083943
PMCPMC11898300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.